Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer IRVINE, CA – January XX, 2026 (GlobeNewswire) ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...

DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...

Purpose-built facility secures Convergent’s drug product manufacturing at the scale needed to meet late-stage CONV01-α clinical studies and commercial demandExpanded partnership designed to drive ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

Closes $36 Million Registered Direct Offering. This article has been disseminated on behalf of Profound Medical Corp. and may include paid advertising. Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) ...

Radiation therapy has been a foundation of cancer care for more than a century. From early X-ray machines to today’s ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") is pleased to announce that it has completed its previously announced private placement ...

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

Researchers will test whether the company's Genomic Prostate Score assay predicts disease progression and outcomes in a prospective cohort.